Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Rapport Therapeutics, Inc. - Common Stock (NQ: RAPP ) 24.62 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 24.62 Bid (Size) 20.40 (5) Ask (Size) 39.14 (1) Prev. Close 24.62 Today's Range 24.62 - 24.62 52wk Range 16.55 - 29.74 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November Today 7:00 EST From Rapport Therapeutics, Inc. Via GlobeNewswire This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday October 18, 2024 Via Benzinga Performance YTD +18.37% +18.37% 1 Month +18.37% +18.37% 3 Month +19.98% +19.98% 6 Month +18.37% +18.37% 1 Year +18.37% +18.37% More News Read More Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences September 05, 2024 From Rapport Therapeutics, Inc. Via GlobeNewswire Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit August 29, 2024 From Rapport Therapeutics, Inc. Via GlobeNewswire The 3 Best Healthcare Stocks to Buy in August 2024 August 12, 2024 Via InvestorPlace RAPP Stock Earnings: Rapport Therapeutics Misses EPS for Q2 2024 August 10, 2024 Via InvestorPlace Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update August 08, 2024 From Rapport Therapeutics, Inc. Via GlobeNewswire 3 Under-The-Radar Healthcare Stocks to Buy for Outsized Returns August 06, 2024 Via InvestorPlace Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain July 29, 2024 From Rapport Therapeutics, Inc. Via GlobeNewswire Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement June 12, 2024 From Rapport Therapeutics, Inc. Via GlobeNewswire Why Contango Ore Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 11, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
